Vanzacaftor, Tezacaftor, Deutivacaftor

Alyftrek 125 MG/50 MG/10 MG Comprimidos Recubiertos con Pelicula

10,60 mg + 50 mg + 125 mg comprimido recubierto con películaSpainMarketedAuthorised 13 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AlyftrekEuropean UnionAuthorised

AlyftrekCanada · 125 MG + 50 MG + 10 MG · Tablet · Vertex Pharmaceuticals (Canada) IncorporatedSame brand
AlyftrekCanada · 50 MG + 20 MG + 4 MG · Tablet · Vertex Pharmaceuticals (Canada) IncorporatedSame brand
AlyftrekItaly · Compressa rivestita con film · Vertex Pharmaceuticals (Ireland) LimitedSame brand
Alyftrek 125 mg/50 mg/10 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Vertex Pharmaceuticals (Ireland) LimitedSame brand
Alyftrek 50 mg/20 mg/4 mg filmomhulde tablettenNetherlands · Filmomhulde tablet · Vertex Pharmaceuticals (Ireland) LimitedSame brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vanzacaftor, Tezacaftor, Deutivacaftor

Alyftrek 125 MG/50 MG/10 MG Comprimidos Recubiertos con Pelicula

10,60 mg + 50 mg + 125 mg comprimido recubierto con películaSpainMarketedAuthorised 13 Aug 2025

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

AlyftrekEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AlyftrekNew Zealand · Tab vanzacaftor 4 mg with tezacaftor 20 mg and deutivacaftor 50 mg

AlyftrekNew Zealand · Tab vanzacaftor 10 mg with tezacaftor 50 mg and deutivacaftor 125 mg

AlyftrekUnited States · 125MG; 50MG; 10MG BASE, 50MG; 20MG; 4MG BASE · tablet · Vertex Pharms INC

Packs

Pack	Code	Status
ALYFTREK 125 MG/50 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 56 comprimidos	768306

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Vanzacaftor, Tezacaftor, Deutivacaftor
Strength: 10,60 mg + 50 mg + 125 mg
Dosage form: comprimido recubierto con película
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 13 Aug 2025
Registration: 1251943002
Marketing authorisation holder: Vertex Pharmaceuticals (Ireland) Limited
Procedure: EU centralised
Supply: Uso Hospitalario
EU number: EU/1/25/1943